We compared the results in the UM cell lines with the effect on cell lines with a BRAF or NRAS mutation (i.e. melanoma cell line OCM3 [BRAF-mut] and the CoM cell lines CRMM1 [BRAF-mut] and CRMM2 [NRAS-mut]). This evidence concerns the gene BRAF and melanoma.